State Street
CERE

State Street’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

State Street’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,109,886
Closed -$127M – 4394
2024
Q2 		$127M Sell
3,109,886
-418,584
-12% -$17.4M 0.01% 1117
2024
Q1 		$149M Buy
3,528,470
+676,651
+24% +$28.4M 0.01% 1056
2023
Q4 		$121M Sell
2,851,819
-48,516
-2% -$1.39M 0.01% 1166
2023
Q3 		$63.3M Buy
2,900,335
+132,058
+5% +$3.3M ﹤0.01% 1475
2023
Q2 		$88M Sell
2,768,277
-369,309
-12% -$11.3M ﹤0.01% 1311
2023
Q1 		$76.5M Sell
3,137,586
-286,634
-8% -$8.41M ﹤0.01% 1367
2022
Q4 		$108M Buy
3,424,220
+704,948
+26% +$19.9M 0.01% 1114
2022
Q3 		$76.8M Buy
2,719,272
+304,798
+13% +$9.08M ﹤0.01% 1295
2022
Q2 		$63.8M Buy
2,414,474
+252,378
+12% +$7.17M ﹤0.01% 1465
2022
Q1 		$75.7M Sell
2,162,096
-55,152
-2% -$1.61M ﹤0.01% 1492
2021
Q4 		$71.9M Buy
2,217,248
+55,476
+3% +$1.96M ﹤0.01% 1551
2021
Q3 		$63.8M Buy
2,161,772
+852,253
+65% +$23.9M ﹤0.01% 1623
2021
Q2 		$33.5M Buy
1,309,519
+377,383
+40% +$5.4M ﹤0.01% 2138
2021
Q1 		$12.8M Buy
+932,136
New +$13.6M ﹤0.01% 2620

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

State Street's CERE Position: Q3 2024 in Review

State Street sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 3,109,886 shares — an estimated $127M sold.

State Street first reported a position in CERE in Q1 2021 and held it in 14 quarters. The position peaked at $149M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • State Street reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • State Street sold 3,109,886 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $127M.
  • State Street first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2021 and held it in 14 quarters.
  • State Street's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $149M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on State Street's 13F filing for Q3 2024, filed 14 Nov 2024.